CPC A61N 1/0504 (2013.01) [A61N 1/059 (2013.01); A61N 1/37512 (2017.08); A61N 1/0563 (2013.01); A61N 1/368 (2013.01); A61N 1/37518 (2017.08)] | 17 Claims |
1. A subcutaneously implantable device comprising:
a housing;
a clip attached to a top side of the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue, wherein the clip includes a top portion that is configured to be positioned on a first side of the muscle, the bone, and/or the first tissue and the housing is configured to be positioned on a second side of the muscle, the bone, and/or the first tissue;
a drug pump and a drug reservoir in the housing, wherein the drug pump is fluidly connected to the drug reservoir;
a first prong with a lumen extending through the first prong and having a proximal end attached to the housing and the drug pump, and a distal end extending away from the housing that is configured to contact an organ, a nerve, and/or a second tissue, wherein the first prong is fluidly connected to the drug pump; and
circuitry in the housing in electrical communication with the drug pump that is configured to deliver a signal to the drug pump to provide a targeted or systemic therapeutic drug to the organ, the nerve, and/or the second tissue through the lumen running through the first prong.
|